Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Jun;36(6):1316–1321. doi: 10.1128/aac.36.6.1316

Mycolic acid synthesis: a target for ethionamide in mycobacteria?

A Quémard 1, G Lanéelle 1, C Lacave 1
PMCID: PMC190338  PMID: 1416831

Abstract

Striking structural analogies exist between the two specific antimycobacterial drugs ethionamide (ETH) and isoniazid (INH), and they share several inhibitory properties in susceptible species of mycobacteria. The effect of ETH on mycolic acid synthesis was studied in whole cells and in cell extracts of various species, since this synthesis is one direct target for INH, as we recently demonstrated in cell extracts of Mycobacterium aurum. It was shown in the present study that there is not a direct relationship between ETH susceptibility and mycolic acid inhibition. This observation could explain the lack of cross-resistance between the two drugs. The presence of ETH disturbed mycolic acid synthesis in both resistant and susceptible mycobacteria. Synthesis of oxygenated species of mycolic acid was inhibited, while that of diunsaturated acids was either slightly altered or even increased. In contrast, INH inhibited the synthesis of all kinds of mycolic acids in the same way in all susceptible strains and had no effect on mycolic acid synthesis in resistant strains. In the presence of ETH, the unsaturated mycolic acid molecules presented a methyl end different from the usual one. These data strongly suggest that the normal unsaturated mycolic acid species are not the precursors of the oxygenated types. Moreover, they show that ETH probably acts early in the pathway leading to oxygenated mycolic acid.

Full text

PDF
1317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begg W. H., Jenne J. W. Capacity of tubercle bacilli for isoniazid accumulation. Am Rev Respir Dis. 1970 Jul;102(1):94–96. doi: 10.1164/arrd.1970.102.1.94. [DOI] [PubMed] [Google Scholar]
  2. DUNBAR J. M. L'apparition de formes non acido-résistantes de Mycobacterium tuberculosis en présence d'isoniazide, de cyclosérine et du thioamide de l'acide alpha-éthyl iso-nicotique. Ann Inst Pasteur (Paris) 1957 Apr;92(4):451–458. [PubMed] [Google Scholar]
  3. Daffé M., Lanéelle M. A., Asselineau C., Lévy-Frébault V., David H. Intérêt taxonomique des acides gras des mycobactéries: proposition d'une méthode d'analyse. Ann Microbiol (Paris) 1983 Sep-Oct;134B(2):241–256. [PubMed] [Google Scholar]
  4. Etemadi A. H. Corrélations structurales et biogénétiques des acides mycoliques en rapport avec la phylogenèse de quelques genres d'Actinomycétales. Bull Soc Chim Biol (Paris) 1967;49(6):695–706. [PubMed] [Google Scholar]
  5. Lacave C., Laneelle M. A., Daffe M., Montrozier H., Laneelle G. Mycolic acid metabolic filiation and location in Mycobacterium aurum and Mycobacterium phlei. Eur J Biochem. 1989 May 1;181(2):459–466. doi: 10.1111/j.1432-1033.1989.tb14747.x. [DOI] [PubMed] [Google Scholar]
  6. Lacave C., Lanéelle M. A., Lanéelle G. Mycolic acid synthesis by Mycobacterium aurum cell-free extracts. Biochim Biophys Acta. 1990 Feb 23;1042(3):315–323. doi: 10.1016/0005-2760(90)90159-u. [DOI] [PubMed] [Google Scholar]
  7. Lacave C., Quémard A., Lanéelle G. Cell-free synthesis of mycolic acids in Mycobacterium aurum: radioactivity distribution in newly synthesized acids and presence of cell wall in the system. Biochim Biophys Acta. 1990 Jun 28;1045(1):58–68. doi: 10.1016/0005-2760(90)90203-a. [DOI] [PubMed] [Google Scholar]
  8. Lanéelle M. A., Lacave C., Daffé M., Lanéelle G. Mycolic acids of Mycobacterium aurum. Structure and biogenetic implications. Eur J Biochem. 1988 Nov 15;177(3):631–635. doi: 10.1111/j.1432-1033.1988.tb14416.x. [DOI] [PubMed] [Google Scholar]
  9. Lapchine L., Asselineau C. Présence d'une bactériophage chez Mycobacterium phlei. Ann Microbiol (Paris) 1981 Mar-Apr;132(2):129–139. [PubMed] [Google Scholar]
  10. Lopez-Marin L. M., Quemard A., Laneelle G., Lacave C. Ethylenic mycolic acid biosynthesis: extension of the biosynthetic model using cell-free extracts of Mycobacterium aurum and Mycobacterium smegmatis. Biochim Biophys Acta. 1991 Oct 15;1086(1):22–28. doi: 10.1016/0005-2760(91)90150-g. [DOI] [PubMed] [Google Scholar]
  11. Luquin M., Roussel J., Lopez-Calahorra F., Lanéelle G., Ausina V., Lanéelle M. A. A novel mycolic acid in a Mycobacterium sp. from the environment. Eur J Biochem. 1990 Sep 24;192(3):753–759. doi: 10.1111/j.1432-1033.1990.tb19286.x. [DOI] [PubMed] [Google Scholar]
  12. Quémard A., Lacave C., Lanéelle G. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob Agents Chemother. 1991 Jun;35(6):1035–1039. doi: 10.1128/aac.35.6.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SCHAEFER W. B. Effect of isoniazid on the dehydrogenase activity of Mycobacterium tuberculosis. J Bacteriol. 1960 Feb;79:236–245. doi: 10.1128/jb.79.2.236-245.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Takayama K., Wang L., David H. L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1972 Jul;2(1):29–35. doi: 10.1128/aac.2.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Winder F. G., Collins P. B., Whelan D. Effects of ethionamide and isoxyl on mycolic acid synthesis in Mycobacterium tuberculosis BCG. J Gen Microbiol. 1971 Jun;66(3):379–380. doi: 10.1099/00221287-66-3-379. [DOI] [PubMed] [Google Scholar]
  16. Winder F. G., Rooney S. A. The effects of isoniazid on the carbohydrates of Mycobacterium tuberculosis BCG. Biochem J. 1970 Apr;117(2):355–368. doi: 10.1042/bj1170355. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES